(FN) Fabrinet - Ratings and Ratios
Optical Components, Transceivers, Lasers, Sensors, Optical Substrates
FN EPS (Earnings per Share)
FN Revenue
Description: FN Fabrinet October 31, 2025
Fabrinet (NYSE:FN) is a contract manufacturer that specializes in high-precision optical, electro-mechanical, and electronic assemblies for customers across North America, Asia-Pacific, and Europe. Its service portfolio spans design-for-manufacturing, supply-chain management, PCB assembly, advanced packaging, integration, final testing, and delivery of complex optical components such as reconfigurable optical add-drop multiplexers (ROADMs), amplifiers, modulators, transceivers, tunable lasers, active optical cables, and a range of lasers and sensors for telecom, data-center, automotive, medical, and industrial applications.
Key quantitative touchpoints (FY 2023): revenue of roughly $1.1 billion, gross margin hovering near 30 %, and a backlog that grew ~12 % YoY, driven largely by rising demand for data-center interconnects and 5G-enabled transport networks. The global optical components market is projected to expand at a CAGR of ~7 % through 2029, while semiconductor-related CAPEX in the U.S. and Europe remains a primary macro driver for Fabrinet’s high-mix, high-value contracts. A notable risk is the ongoing semiconductor supply-chain tightening, which can compress lead times and pressure pricing for custom optical modules.
If you want a deeper, data-rich assessment of Fabrinet’s valuation dynamics, the ValueRay platform offers granular financial models and scenario analyses that can help you test the sensitivity of these drivers.
FN Stock Overview
| Market Cap in USD | 15,784m |
| Sub-Industry | Electronic Manufacturing Services |
| IPO / Inception | 2010-06-25 |
FN Stock Ratings
| Growth Rating | 89.3% |
| Fundamental | 73.7% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 77.8% |
| Analyst Rating | 3.89 of 5 |
FN Dividends
Currently no dividends paidFN Growth Ratios
| Growth Correlation 3m | 90.8% |
| Growth Correlation 12m | 69.6% |
| Growth Correlation 5y | 92.2% |
| CAGR 5y | 61.48% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.64 |
| CAGR/Mean DD 3y (Pain Ratio) | 5.55 |
| Sharpe Ratio 12m | 2.15 |
| Alpha | 79.87 |
| Beta | 1.050 |
| Volatility | 56.88% |
| Current Volume | 845.9k |
| Average Volume 20d | 518.2k |
| Stop Loss | 466.9 (-4.1%) |
| Signal | 1.57 |
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (332.5m TTM) > 0 and > 6% of Revenue (6% = 205.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -8.29pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 47.35% (prev 50.46%; Δ -3.11pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 328.4m <= Net Income 332.5m (YES >=105%, WARN >=100%) |
| Net Debt (-301.0m) to EBITDA (408.6m) ratio: -0.74 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (36.1m) change vs 12m ago -1.23% (target <= -2.0% for YES) |
| Gross Margin 12.09% (prev 12.35%; Δ -0.26pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 132.3% (prev 123.3%; Δ 9.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| error: Interest Coverage Ratio cannot be calculated (needs EBITDA TTM and Interest Expense TTM) |
Altman Z'' 9.68
| (A) 0.57 = (Total Current Assets 2.43b - Total Current Liabilities 809.8m) / Total Assets 2.83b |
| (B) 0.74 = Retained Earnings (Balance) 2.09b / Total Assets 2.83b |
| (C) 0.14 = EBIT TTM 355.2m / Avg Total Assets 2.58b |
| (D) 2.48 = Book Value of Equity 2.10b / Total Liabilities 849.6m |
| Total Rating: 9.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 73.71
| 1. Piotroski 4.50pt = -0.50 |
| 2. FCF Yield 1.39% = 0.70 |
| 3. FCF Margin 6.05% = 1.51 |
| 4. Debt/Equity 0.00 = 2.50 |
| 5. Debt/Ebitda -0.74 = 2.50 |
| 6. ROIC - WACC (= 7.70)% = 9.63 |
| 7. RoE 17.60% = 1.47 |
| 8. Rev. Trend 96.35% = 7.23 |
| 9. EPS Trend -26.44% = -1.32 |
What is the price of FN shares?
Over the past week, the price has changed by +9.68%, over one month by +31.49%, over three months by +48.40% and over the past year by +111.49%.
Is Fabrinet a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FN is around 656.05 USD . This means that FN is currently undervalued and has a potential upside of +34.74% (Margin of Safety).
Is FN a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the FN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 364.1 | -25.2% |
| Analysts Target Price | 364.1 | -25.2% |
| ValueRay Target Price | 740.6 | 52.1% |
FN Fundamental Data Overview November 04, 2025
P/E Trailing = 48.0972
P/S = 4.6161
P/B = 6.6627
P/EG = 1.19
Beta = 1.05
Revenue TTM = 3.42b USD
EBIT TTM = 355.2m USD
EBITDA TTM = 408.6m USD
Long Term Debt = 5.47m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.79m USD (from shortTermDebt, last quarter)
Debt = 5.47m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -301.0m USD (from netDebt column, last quarter)
Enterprise Value = 14.86b USD (15.78b + Debt 5.47m - CCE 934.2m)
Interest Coverage Ratio = unknown (Ebit TTM 355.2m / Interest Expense TTM 0.0)
FCF Yield = 1.39% (FCF TTM 206.8m / Enterprise Value 14.86b)
FCF Margin = 6.05% (FCF TTM 206.8m / Revenue TTM 3.42b)
Net Margin = 9.72% (Net Income TTM 332.5m / Revenue TTM 3.42b)
Gross Margin = 12.09% ((Revenue TTM 3.42b - Cost of Revenue TTM 3.01b) / Revenue TTM)
Gross Margin QoQ = 12.23% (prev 11.72%)
Tobins Q-Ratio = 5.25 (Enterprise Value 14.86b / Total Assets 2.83b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 5.47m)
Taxrate = 6.47% (6.03m / 93.2m)
NOPAT = 332.2m (EBIT 355.2m * (1 - 6.47%))
Current Ratio = 3.00 (Total Current Assets 2.43b / Total Current Liabilities 809.8m)
Debt / Equity = 0.00 (Debt 5.47m / totalStockholderEquity, last quarter 1.98b)
Debt / EBITDA = -0.74 (Net Debt -301.0m / EBITDA 408.6m)
Debt / FCF = -1.46 (Net Debt -301.0m / FCF TTM 206.8m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.74% (Net Income 332.5m / Total Assets 2.83b)
RoE = 17.60% (Net Income TTM 332.5m / Total Stockholder Equity 1.89b)
RoCE = 18.74% (EBIT 355.2m / Capital Employed (Equity 1.89b + L.T.Debt 5.47m))
RoIC = 17.58% (NOPAT 332.2m / Invested Capital 1.89b)
WACC = 9.88% (E(15.78b)/V(15.79b) * Re(9.88%) + D(5.47m)/V(15.79b) * Rd(0.0%) * (1-Tc(0.06)))
Discount Rate = 9.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.76%
[DCF Debug] Terminal Value 75.71% ; FCFE base≈270.0m ; Y1≈333.0m ; Y5≈568.2m
Fair Price DCF = 196.3 (DCF Value 7.01b / Shares Outstanding 35.7m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -26.44 | EPS CAGR: -56.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: 96.35 | Revenue CAGR: 12.66% | SUE: 3.62 | # QB: 3
Additional Sources for FN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle